Jung Wook Park

Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial

Kohei Shitara, Florian Lordick, Yung‐Jue Bang et al. · The Lancet · 2023 · 609 citations

Oncology, Esophageal Cancer, Gastrointestinal Oncology +9

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

Erin A. Bohula, Benjamin M. Scirica, Silvio E. Inzucchi et al. · The Lancet · 2018 · 94 citations · Full text

Obesity, Metabolic Syndrome, Camellia-timi 61 +9

Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: Two single-dose, open-label, randomized-sequence, crossover studies

Daphne Williams, Bin Peng, Christine K. Bailey et al. · Clinical Therapeutics · 2009 · 86 citations

Nutrition, Pharmacology, Healthy Adult Subjects +5

Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers

Alicia J. Allred, Carolyn J. Bowen, Jung Wook Park et al. · British Journal of Clinical Pharmacology · 2011 · 71 citations · Full text

Effect of Hepatic or Renal Impairment on Eltrombopag Pharmacokinetics

John W. Bauman, Carolyn T. Vincent, Bin Peng et al. · The Journal of Clinical Pharmacology · 2010 · 36 citations